Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
Point72 Asset Management, L.P. | 477 0.100% |
-2,103,725 (-99.98%) |
Filing History |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | BellRing Brands, Inc. BRBR |
Point72 Asset Management, L.P. | 2,228,070 1.600% |
2,228,070 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Otonomy, Inc. OTIC |
Point72 Asset Management, L.P. | 0 0.000% |
-5,450,000 (Position Closed) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management, L.P. | 8,647 0.200% |
-176,719 (-95.34%) |
Filing History |
| 2023-02-14 4:05 pm Sale |
2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
Point72 Asset Management, L.P. | 0 0.000% |
-470,000 (Position Closed) |
Filing History |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Point72 Asset Management, L.P. | 1,187,598 1.900% |
-1,470,364 (-55.32%) |
Filing History |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | Merrimack Pharmaceuticals, Inc. MACK |
Point72 Asset Management, L.P. | 0 0.000% |
-900,981 (Position Closed) |
Filing History |
| 2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Point72 Asset Management, L.P. | 830,000 3.200% |
-1,726,976 (-67.54%) |
Filing History |
| 2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 22 0.100% |
-10,609,978 (-100.00%) |
Filing History |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Point72 Asset Management, L.P. | 115,484 0.200% |
-1,644,764 (-93.44%) |
Filing History |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Point72 Asset Management, L.P. | 556,252 2.200% |
-1,304,418 (-70.10%) |
Filing History |
| 2023-02-14 4:01 pm Sale |
2022-12-31 | 13G | Affimed N.V. AFMD |
Point72 Asset Management, L.P. | 422,701 2.800% |
-762,858 (-64.35%) |
Filing History |
| 2023-02-14 4:01 pm Sale |
2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Point72 Asset Management, L.P. | 392,151 0.900% |
-1,968,718 (-83.39%) |
Filing History |
| 2023-02-14 4:00 pm Sale |
2022-12-31 | 13G | Achilles Therapeutics plc ACHL |
Point72 Asset Management, L.P. | 1,413,809 3.600% |
-667,241 (-32.06%) |
Filing History |
| 2023-02-13 8:33 pm Purchase |
2023-02-10 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Point72 Asset Management, L.P. | 1,250,000 6.500% |
1,250,000 (New Position) |
Filing History |
| 2023-02-08 4:34 pm Purchase |
2023-02-03 | 13G | MediWound Ltd. MDWD |
Point72 Asset Management, L.P. | 821,500 8.900% |
821,500 (New Position) |
Filing History |
| 2023-01-05 5:31 pm Purchase |
2023-01-04 | 13G | Fastly, Inc. FSLY |
Point72 Asset Management, L.P. | 6,209,691 5.000% |
6,209,691 (New Position) |
Filing History |
| 2023-01-04 5:04 pm Purchase |
2023-01-03 | 13G | Pulmonx Corporation LUNG |
Point72 Asset Management, L.P. | 1,971,810 5.300% |
1,971,810 (New Position) |
Filing History |
| 2022-11-14 5:11 pm Purchase |
2022-11-10 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 3,398,661 7.100% |
3,398,661 (New Position) |
Filing History |
| 2022-11-09 9:10 pm Purchase |
2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 960,870 9.990% |
960,870 (New Position) |
Filing History |